High-Dose vitamin d tested to boost lymphoma treatment
NCT ID NCT07366450
Summary
This study aims to see if giving a large, upfront dose of vitamin D (ergocalciferol) can raise vitamin D levels to normal faster and more safely than giving smaller weekly doses in people newly diagnosed with aggressive non-Hodgkin lymphoma. All participants will receive standard chemotherapy for their cancer. Researchers will compare the two vitamin D dosing methods to see which one works better and is safer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA, NON-HODGKIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Phramonkutklao Hospital
Bangkok, 10400, Thailand
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.